Impax Laboratories Inc. and Amneal Pharmaceuticals LLC are close to agreement on a merger that would create the nation’s fifth-largest generic-drug company by revenue, according to people familiar with the matter.
NYS Entity Status
NYS Filing Date
DECEMBER 09, 2013
NYS DOS ID#
NYS Entity Type
FOREIGN LIMITED LIABILITY COMPANY
2013 - ARBOR PHARMA LLC
2013 - ARBOR PHARMACEUTICALS, LLC
Around the Web
- Impax Laboratories and Amneal Pharmaceuticals Near Merger Agreement
Monday Oct 16, 2017
- Inside a Secretive Group Where Women Are Branded
By BARRY MEIER - Wednesday Oct 18, 2017
A self-help organization in Albany called Nxivm has begun to unravel as members reveal disturbing practices and fears of blackmail.
- The Strange Case of Martin Shkreli Is Wrapping Up
By STEPHANIE CLIFFORD - Wednesday Jul 26, 2017
An unusual trial has featured victims who actually made money and defense lawyers who paint their client as an erratic misfit and want more victims to testify.
- Stealthy NY Startup Rocket Pharma Merges With Inotek, Heads to Nasdaq
By Ben Fidler - Tuesday Sep 12, 2017
Rocket Pharmaceuticals, a stealthy gene therapy startup in New York City, has made its first splash. Through a merger with struggling Inotek Pharmaceuticals (NASDAQ: ITEK), Rocket, a company developing treatments for a variety of rare blood diseases, has taken itself public. Rocket shareholders are expected to own 81 percent of the combined company, with Inotek […]
- Phrixus to Launch Clinical Trials for Duchenne Drug in Early 2018
By Sarah Schmid Stevenson - Monday Oct 16, 2017
After showing some early promise in treating European patients, Ann Arbor, MI-based Phrixus Pharmaceuticals, a startup developing drugs to treat cardiac and respiratory problems in young males with Duchenne muscular dystrophy, is preparing to launch U.S. clinical trials early next year. During the first quarter of 2018, Phrixus will dose the first patient with its […]